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 NURSING NEWS 

Volume 23a Number 1

St. Cloud Hospital, St. Cloud, MN

January, 2002

Nursing News
Special Edition
Adult Blood/
Blood Product
Infusion Protocol Order
Beginning February 1, 2002, implementation of
placing the attached Adult Blood/Blood Product
Infusion Protocol Order in patient charts any
time blood is ordered for non-surgical patients is
being requested.
This form was implemented previously but
discontinued. It has been revised and now reimplemented due to a major citation from
JCAHO. JCAHO makes us responsible for
documenting blood administration informed
consent; that is what they found missing
during our last survey. This revised form
imbeds the necessary informed consent
documentation, making it automatic without
requiring another form and another physician
signature.
The Medical Care Review Committee and the
Medical Staff Executive Committee have
approved these changes and support having this
order placed in patient charts when blood is
ordered for non-surgical patients. As always,
the Medical Staff Executive Committee wants
to assure compliance with regulatory
mandates while making their impact on
physicians as minimally intrusive as possible.
These forms have been printed and are available
in Distribution.
Submitted by:
Mary Buhl

Pain Assessment,
Changes in Documentation
All patients must be assessed for pain upon
admission or upon the first visit. This includes
all inpatient units, including Mental Health Unit
and Recovery Plus. This standard must also be
addressed in most outpatient areas. The
following steps outline what must be done for
the assessment and management of pain.
Step 1:
Screen for the presence of pain.
Is the patient having pain?
Is the patient concerned about pain?
Does the patient have a history of chronic
pain?
Step 2:
If the patient answers yes to the above screening
question, then a comprehensive assessment must
be completed.
A comprehensive pain assessment includes the
following parameters:
• Onset
• Location
• Duration
• Characteristics
• Aggravating factors
• Relieving factors
• Treatment tried
Step 3:
Establish and individualized pain management
goal.
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Step 4:
If pain is rated > 3/10 or is unacceptable to the
patient, there will be an intervention to reduce
pain
Step 5:
Reassess for the presence of pain after each
intervention until pain intensity is at or below the
patient’s goal and then every four hours while
awake until pain is resolved or until discharge.
If pain is not improving with appropriate
interventions, additional measures should be
taken unless reasons for waiting are indicated.
The systems for documenting this information
have been revised.
• The Functional Health Assessment has been
updated to include the comprehensive pain
assessment. (See diagram A)
• Stickers have been developed for the
comprehensive pain assessment and
reassessment (see diagram B and C).
• The Physical Findings Pain assessment
screen has been revised in JRS. (See
diagram D)
Additional information is available from you
Education Council Representative and/or the
person responsible for education in your area.
Pain Assessment
Kay Greenlee, MSN, RN, CNS
Coordinator/Clinical Nurse Specialist
Comprehensive Pain Program

Diabetes Update
Information on:

JANUARY, 2002

•

Note: This product is clear (i.e., it's a
solution). Be careful not to confuse this
insulin with other insulins! Because of
the risk of confusing the name Lantus
with the name Lente, staff is encouraged
to call this insulin Glargine

•

Typical Glargine schedule:
- Usually patients will be on Glargine
at HS, and either Humalog or Regular
before each meal. This may be
ordered as a set amount, or as a
sliding scale amount.
- Sometimes patients may be on
Glargine at HS, and pills for diabetes
during the day.

•

Action: Works over 22-24 hours, and has
no peak.

•

Given at bedtime (about 2200). Used for
long-acting insulin and replaces NPH or
Ultralente insulin.

•

Class: insulin analog. (Modified human
insulin)

•

Route of Administration: subcutaneous.

•

Labeling: Lantus® (glargine) has a
lavender label to help identify the product

•

Snacks: Patients using glargine (Lantus)
often do not need a bedtime snack, as
there will not be an insulin peak
occurring during the night. These patients
will usually not need a mid a.m. or mid
p.m. snack, either.

Insulin glargine (Brand name: Lantus).
•

Glargine (Lantus) must not be diluted
or mixed with any other insulin or
solution, as it may result in a changed
action, leading to hyper- or
hypoglycemia.

Submitted by:
Diabetes Nurse Educators
LeAnne Troxel
Barb Isaacson
Carol Dirks
Pat Osburne

